Harvard Bioscience Inc (HBIO)
3.70
-0.24
(-6.09%)
USD |
NASDAQ |
Apr 19, 16:00
3.70
0.00 (0.00%)
After-Hours: 19:13
Harvard Bioscience Cash from Operations (TTM): 14.03M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 14.03M |
| September 30, 2023 | 12.40M |
| June 30, 2023 | 8.692M |
| March 31, 2023 | 4.95M |
| December 31, 2022 | 1.152M |
| September 30, 2022 | -1.41M |
| June 30, 2022 | -2.719M |
| March 31, 2022 | -1.761M |
| December 31, 2021 | 1.262M |
| September 30, 2021 | 3.635M |
| June 30, 2021 | 5.892M |
| March 31, 2021 | 7.497M |
| December 31, 2020 | 9.331M |
| September 30, 2020 | 9.061M |
| June 30, 2020 | 10.62M |
| March 31, 2020 | 8.906M |
| December 31, 2019 | 8.045M |
| September 30, 2019 | 8.418M |
| June 30, 2019 | 3.826M |
| March 31, 2019 | 4.446M |
| December 31, 2018 | 2.884M |
| September 30, 2018 | -0.648M |
| June 30, 2018 | 2.917M |
| March 31, 2018 | 2.115M |
| December 31, 2017 | 1.057M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.723M |
| June 30, 2017 | 5.032M |
| March 31, 2017 | 5.499M |
| December 31, 2016 | 5.383M |
| September 30, 2016 | 5.42M |
| June 30, 2016 | 1.902M |
| March 31, 2016 | 0.476M |
| December 31, 2015 | 0.705M |
| September 30, 2015 | 0.204M |
| June 30, 2015 | 0.884M |
| March 31, 2015 | 2.782M |
| December 31, 2014 | 4.351M |
| September 30, 2014 | 4.337M |
| June 30, 2014 | 5.166M |
| March 31, 2014 | 4.556M |
| December 31, 2013 | 4.06M |
| September 30, 2013 | 4.217M |
| June 30, 2013 | 5.289M |
| March 31, 2013 | 7.033M |
| December 31, 2012 | 8.062M |
| September 30, 2012 | 9.299M |
| June 30, 2012 | 8.006M |
| March 31, 2012 | 7.109M |
| December 31, 2011 | 6.648M |
| September 30, 2011 | 8.254M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-2.719M
Minimum
Jun 2022
14.03M
Maximum
Dec 2023
5.886M
Average
7.497M
Median
Mar 2021
Cash from Operations (TTM) Benchmarks
| Bruker Corp | 350.10M |
| Azenta Inc | 70.94M |
| Bionano Genomics Inc | -125.18M |
| Akoya Biosciences Inc | -50.90M |
| Singular Genomics Systems Inc | -73.65M |